Sage Journals: Discover world-class research

Free access

Research article

First published 2011-11

Increased Wild-Type N-Ras Activation by Neurofibromin Down-Regulation Increases Human Neuroblastoma Stem Cell Malignancy

Dan Han, Barbara A. Spengler, Robert A. Ross

Genes & Cancer

Open access

Research article

First published 2018-3

CD133 expression and MYCN amplification induce chemoresistance and reduce average survival time in pediatric neuroblastoma

Zhi-Yong Zhong, Bao-Jun Shi, Hui Zhou [...]

Journal of International Medical Research

Open access

Research article

First published 2023-06

A Retrospective Analysis of the Therapeutic Outcomes of 117 Neuroblastoma Patients Treated at a Single Pediatric Oncology Center in China

Uet Yu, Huanli Xu, Senmin Chen [...]

Cancer Control

Free access

Announcement

First published 2012

Surface markers in stem cells and cancer from the perspective of glycomic analysis

Huan-Chieh Cho, Chien- Huang Liao, Alice L Yu [...]

The International Journal of Biological Markers

Open access

Review article

First published 2022-1

Emerging Roles of DLK1 in the Stem Cell Niche and Cancer Stemness

Elisa Stellaria Grassi, Alexander Pietras

Journal of Histochemistry & Cytochemistry

Retricted access

Research article

First published 2020-12

An overview of neuroblastoma cell lineage phenotypes and in vitro models

Sheron Campos Cogo, Thatyanne Gradowski Farias da Costa do Nascimento, Fernanda de Almeida Brehm Pinhatti [...]

Experimental Biology and Medicine

Open access

Review article

First published 2019-9

Comparison of survivor scores for differentiation therapy of cancer to those for checkpoint inhibition: Half full or half empty

Stewart Sell, Zoran Ilic

Tumor Biology

Retricted access

Research article

First published 1998-02

Minimal Residual Disease in Solid Tumor Malignancies: A Review

Amy A. Ross

Stem Cells and Development

Retricted access

Review article

First published 2016-5

Dinutuximab

Cady Ploessl, Alice Pan, Kathryn T. Maples [...]

Annals of Pharmacotherapy

Retricted access

Research article

First published 2013-2

Targeted Immunotherapy for High-Risk Neuroblastoma—The Role of Monoclonal Antibodies

Kerry Parsons, Brooke Bernhardt, Brandy Strickland

Annals of Pharmacotherapy

Search results